The Second Affiliated Hospital Of Chongqing Medical University

This study tests a new way to place a stent (a small tube) in the liver to treat bleeding or fluid buildup caused by cirrhosis. The new technique uses a smaller balloon to keep the stent narrow at first, which may lower the chance of a brain complication called hepatic encephalop…

This study tests a new combination of drugs to help people with chronic hepatitis B achieve a 'functional cure'—meaning the virus is no longer active in the body. About 120 adults aged 18-70 will receive an immune-boosting drug (anti-PD-1 antibody) along with standard antivirals.…

This study tests a new two-drug combination (ASC22 and Peg-IFNa) to see if it can functionally cure chronic hepatitis B. It involves 150 adults with low virus levels who are not on other treatments. The goal is to raise the cure rate above 50% without needing lifelong medication.

This study tests a new combination of drugs (an immune checkpoint inhibitor and interferon) to help the body clear the hepatitis B virus. The goal is to achieve a functional cure, meaning the virus is controlled without lifelong medication. About 120 adults with chronic hepatitis…

This study tests a new way to give radiation for lung cancer. Doctors will use a special scan to see which parts of the lung are working best, then aim the radiation away from those areas. The goal is to reduce lung damage and side effects like breathing problems. About 100 adult…